GILEAD SCIENCES, INC. - Common Stock (GILD)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Total 13F shares
1,044,478,354
Share change
+2,875,940
Total reported value
$84,656,377,441
Put/Call ratio
109%
Price per share
$81.01
Number of holders
1,763
Value change
+$255,439,953
Number of buys
744
Number of sells
793

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2023

As of 31 Dec 2023, GILEAD SCIENCES, INC. - Common Stock (GILD) was held by 1,763 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,044,478,354 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Capital Research Global Investors, STATE STREET CORP, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, and FMR LLC. This page lists 1,763 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.